Charles Ewing

Charles Ewing

UNVERIFIED PROFILE

Are you Charles Ewing?   Register this Author

Register author
Charles Ewing

Charles Ewing

Publications by authors named "Charles Ewing"

Are you Charles Ewing?   Register this Author

35Publications

798Reads

23Profile Views

HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.

Prostate 2019 Mar 17;79(4):414-424. Epub 2018 Dec 17.

Brady Urological Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23747DOI Listing
March 2019

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Prostate 2018 12 24;78(16):1222-1228. Epub 2018 Jul 24.

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23697DOI Listing
December 2018

Genetic factors influencing prostate cancer risk in Norwegian men.

Prostate 2018 02 27;78(3):186-192. Epub 2017 Nov 27.

Brady Urological Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23453DOI Listing
February 2018

The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Cancer Epidemiol Biomarkers Prev 2015 Sep 24;24(9):1366-72. Epub 2015 Jun 24.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560608PMC
September 2015

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

BJU Int 2014 May 5;113(5):830-5. Epub 2014 Mar 5.

Department of Oncology, Wayne State University, Detroit, MI, USA; Barbara Ann Karmanos Cancer Institute, Population Studies and Disparities Research Program, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984347PMC
May 2014

Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts.

J Cell Mol Med 2012 Jan;16(1):193-201

Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2011.01283.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823105PMC
January 2012

Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Int J Cancer 2011 Jul 16;129(2):424-32. Epub 2010 Nov 16.

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040782PMC
July 2011

Endoglin (CD105) as a urinary and serum marker of prostate cancer.

Int J Cancer 2009 Feb;124(3):664-9

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666305PMC
February 2009

alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.

Mol Cancer Ther 2008 Jun;7(6):1386-97

Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, 1701 Rockland Road, Wilmington, DE 19803, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-2029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527861PMC
June 2008

Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers.

Genes Chromosomes Cancer 2007 Nov;46(11):972-80

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20482DOI Listing
November 2007

Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.

Hum Genet 2006 Nov 25;120(4):471-85. Epub 2006 Aug 25.

Harwick 7, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-006-0219-9DOI Listing
November 2006

A novel role of myosin VI in human prostate cancer.

Am J Pathol 2006 Nov;169(5):1843-54

Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1780223PMC
http://dx.doi.org/10.2353/ajpath.2006.060316DOI Listing
November 2006

Germline ATBF1 mutations and prostate cancer risk.

Prostate 2006 Jul;66(10):1082-5

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20430DOI Listing
July 2006

Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.

Exp Cell Res 2006 Apr 17;312(6):831-43. Epub 2006 Jan 17.

Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2005.11.029DOI Listing
April 2006

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Am J Hum Genet 2005 Aug 29;77(2):219-29. Epub 2005 Jun 29.

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/432377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224525PMC
August 2005

Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.

Cancer Res 2004 Apr;64(7):2523-33

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
April 2004

Cadherin-6: a new prognostic marker for renal cell carcinoma.

J Urol 2004 Jan;171(1):97-101

Department of Urology, Technischen Universitaet Munich, Klinikum rechts der Isar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000101512.47242.79DOI Listing
January 2004

Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.

Cancer Res 2003 Nov;63(21):7365-76

Brady Urological Institute, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
November 2003

Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.

Prostate 2003 Oct;57(2):134-9

Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.10284DOI Listing
October 2003

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.

Prostate 2002 May;51(3):189-200

Department of Urology, Brady Urological Institute, 115 Marburg, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.10087DOI Listing
May 2002

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Cancer Res 2002 Apr;62(8):2220-6

Department of Pathology, Brady Urological Institute, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
April 2002

In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.

Oncogene 2002 Apr;21(17):2679-94

Brady Urological Institute Research Laboratories, The Johns Hopkins Medical Institutions, Baltimore, Maryland, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205352DOI Listing
April 2002